ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880 | +36.2% | 435,841 | +99.1% | 0.00% | – |
| Q2 2023 | $646 | +9.5% | 218,908 | -7.3% | 0.00% | – |
| Q1 2023 | $590 | -10.5% | 236,118 | +13.5% | 0.00% | – |
| Q4 2022 | $659 | -99.9% | 208,089 | +24.8% | 0.00% | -100.0% |
| Q3 2022 | $495,000 | +179.7% | 166,768 | +185.9% | 0.00% | – |
| Q2 2022 | $177,000 | -78.6% | 58,337 | -4.6% | 0.00% | -100.0% |
| Q1 2022 | $826,000 | – | 61,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |